Larson Financial Group’s Cellectis CLLS Stock Holding History

Larson Financial Group’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$113	Hold	75	–	–	﹤0.01%	3739
2026 Q2	$225	Hold	75	–	–	﹤0.01%	3592
2026 Q1	$238	Buy	+75	New	+$287	﹤0.01%	3427

Other funds holding CLLS

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Walleye Partners Madison, Wisconsin $89M AUM 5.66% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

PIS

POM Investment Strategies Raleigh, North Carolina $124M AUM 9.91% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Larson Financial Group's CLLS Position: Q3 2026 in Review

Larson Financial Group held its Cellectis (CLLS) position steady in Q3 2026 at 75 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #3739.

Larson Financial Group first reported a position in CLLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $238 in Q1 2026. 9 funds tracked by Wall St. Rank hold CLLS as of Q3 2026.

Larson Financial Group held 75 shares of Cellectis worth $113 as of Q3 2026.
Larson Financial Group left its Cellectis share count unchanged in Q3 2026.
Cellectis made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3739 holding.
Larson Financial Group first reported a position in Cellectis in Q1 2026 and has held it in 3 quarters since.
Larson Financial Group's Cellectis position peaked at $238 in Q1 2026.
9 funds tracked by Wall St. Rank held Cellectis as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.